Exact Sciences Corp Reports Quarterly Earnings

Exact Sciences Corp, a biotechnology company focused on colorectal cancer detection, has released its quarterly earnings report. Key highlights from the latest quarter include:

• Revenue: $706.8 million USD, representing a 10.86% increase compared to the same period in 2023.
• Net loss per share: $0.54 USD, a decrease from the previous year’s loss of $0.60 USD per share.

The company’s financial performance demonstrates a notable improvement in revenue, driven by strong sales growth. However, the net loss per share has decreased compared to the previous year.

Stock Price Movement

Exact Sciences Corp’s stock price has experienced a notable increase in pre-market trading, driven by the company’s strong revenue growth and raised sales outlook for 2025.